SWISS multinational pharmaceuticals company Novartis is re-imagining global healthcare. It has earned society’s trust through a four-pillar commitment to the highest ethical standards, improved access, contribution to global health, and responsible corporate citizenship. Novartis employees benefit from its focus on CSR, and some 500 associates are signatories to its 2019 Code of Ethics. The company holds itself — and its entire supply chain — to exacting standards. It completed 135 in-depth audits, with active follow-up, across the network last year. Novartis programmes and initiatives have afforded healthcare access to more than 16m patients, and health education and training to another 10m. Novartis strives to deliver medical breakthroughs where they’re most needed — and clinical trials for COVID-19 treatments are under way. The BV judging panel presents Novartis with the 2020 award for Best Pharmaceutical CSR (Europe).
